BIOQUAL Presents Financial Results for Fiscal Year 2012 and Declares Dividend

BIOQUAL (Pinksheets: BIOQ):

2012

2011

        
      
      
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Revenue
        
        
        
        
          $
        
        
          22,667,149
        
        
        
        
          $
        
        
          23,298,689
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Income Before Income Tax
        
        
        
        
          $
        
        
          362,199
        
        
        
        
          $
        
        
          682,304
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Net Income
        
        
        
        
          $
        
        
          213,971
        
        
        
        
          $
        
        
          401,662
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Basic Earnings per Share
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          of Common Stock
        
        
        
        
          $
        
        
          .24
        
        
        
        
          $
        
        
          .45
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Diluted Earnings per Share
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          of Common Stock
        
        
        
        
          $
        
        
          .24
        
        
        
        
          $
        
        
          .45
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Weighted Average
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          Number of Shares Outstanding
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          For Basic Earnings
        
        
        
        
        
        
          895,994
        
        
        
        
        
        
          900,017
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
      
        
          Weighted Average
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          Number of Shares Outstanding
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      
        
          For Diluted Earnings
        
        
        
        
        
        
          895,994
        
        
        
        
        
        
          900,017
        
      
      
        
        
        
        
        
        
        
        
        
        
        
        
        
           
        
      
    
    

BIOQUAL’s Board of Directors has declared a dividend of $0.16 per share for shareholders of record on November 28, 2012, payable on December 18, 2012. This is the twelfth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the actual cost incurred in performing its contracts; uncertainties relating to clinical trials; dependence on third parties; and future capital needs.